While low-dose ISO treatment effectively induces G0/G1 growth arrest by suppressing the key cell cycle regulatory protein cyclin D1 expression [22,23], high-dose ISO triggers an apoptotic response of cancer cells by inhibiting anti-apoptotic XIAP gene transcription [7]. Here, CCND1 is linked to cancer.